Skip to content

First experience with the performance of Geistlich Bio-Oss® Flow in periodontal intrabony defects

First experience with the performance of Geistlich Bio-Oss® Flow in periodontal intrabony defects - Geistlich Bio-Oss® Flow study

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00036536
Enrollment
10
Registered
2025-07-15
Start date
2024-12-19
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

K05.6

Interventions

Group 1: In patients with intrabony defects Bio-Oss Flow will be applied in a minimally invasive approach to augment the bone

Sponsors

Geistlich Pharma AG
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1) Periodontal intrabony defects, assessed from 1.5 to 6 months after initial periodontal therapy (bone depth of = 3 mm) anatomy 2) Adults 18 years or older 3) Signed Informed consent

Exclusion criteria

Exclusion criteria: 1) Presence of acutely infected wounds 2) Patients with a known allergy to collagen 3) Chronic infection at the surgical site 4) Clinical conditions impairing tissue healing

Design outcomes

Primary

MeasureTime frame
Gain of clinical attachment level (CAL) measured with periodontal probe by mm at six months after surgery

Secondary

MeasureTime frame
1. DF: Defect Fill by the difference of defect depth by mm measured with Intraoral/Periapical radiograph at six months after surgery 2. PPD: Reduction of the periodontal pocket probing depth six months after surgery 3. GR: Change of the gingival recession six months after surgery 4. BOP: Bleeding on probing six months after surgery

Countries

Switzerland

Contacts

Public ContactAnton Sculean

Universität Bern, Klinik für Parodontologie

anton.sculean@unibe.ch+41 31 684 06 00

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 7, 2026